Pharmaceutical Company AbbVie Inflated Prices for Two Major Drugs, House Oversight Report Says

Pharmaceutical company AbbVie significantly inflated prices over the past two decades for patients in the U.S. who take the drugs Humira and Imbruvica, a report released Tuesday by the House Oversight and Reform Committee found.

 

 

Photo Credits: AbbVie

Recent Posts

EBITDA CATALYST | Phone/Fax: 888-EBITDA8 (888-324-8328) | 333 Washington Ave N, Suite 300 | Minneapolis, MN 55401

EBITDA Catalyst®, Pricing Power Clarity®, Mission Driven Pricing® and Pricing as a System® are registered trademarks of EBITDA Catalyst.
© 2022 EBITDA Catalyst | All Rights Reserved.